I'd rather take on the back end of a Lindor deal for the simple fact that it's a lot longer away. Stud SS for the next 10 years with the first 7 being performed at an elite level with the last three most likely being a bit above average sounds better than signing Springer through years 31-36/37 where you'll most likely get 3 years of the current product, sounds better to me, regardless of asset losses.